??????????? ?????????????????????????102 Then again, numerous groups are advocating with the incorporation of novel markers, like a intricate karyotype55 or epigenetic subsets, 27,28 into medical practice. These novel prognostic and/or predictive styles will have to be validated in cohorts of patients addressed with specific agents.????????????????